Yanchun Zhao

No. 79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

ZR2-miniCHOP for elderly patients with newly diagnosed diffuse large B-cell lymphoma.

ZR2-miniCHOP for elderly patients with newly diagnosed diffuse large B-cell lymphoma.

Journal: BMC cancer

Published: January 08, 2026

Effects and molecular mechanism of inhibiting p53 signaling pathway by NSUN4 on the resistance to BCL-2 inhibitor for diffuse large B-cell lymphoma.

Effects and molecular mechanism of inhibiting p53 signaling pathway by NSUN4 on the resistance to BCL-2 inhibitor for diffuse large B-cell lymphoma.

Journal: Clinical and experimental medicine

Published: October 28, 2025

Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?

Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?

Journal: Annals of hematology

Published: October 22, 2025

Global, regional, and national burden of lymphoma from 1990 to 2021: a comprehensive analysis based on the global burden of disease study 1990-2021.

Global, regional, and national burden of lymphoma from 1990 to 2021: a comprehensive analysis based on the global burden of disease study 1990-2021.

Journal: European journal of medical research

Published: September 25, 2025

Super-enhancer-associated circPVT1 promotes malignancy of hepatocellular carcinoma via YBX1-mediated RRM2 activation.

Super-enhancer-associated circPVT1 promotes malignancy of hepatocellular carcinoma via YBX1-mediated RRM2 activation.

Journal: Cancer letters

Published: February 08, 2024

m6A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia.

m6A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia.

Journal: Clinical and translational medicine

Published: October 22, 2023

Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients.

Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients.

Journal: Frontiers in oncology

Published: February 23, 2023

circSLC25A13 acts as a ceRNA to regulate AML progression via miR-616-3p/ADCY2 axis.

circSLC25A13 acts as a ceRNA to regulate AML progression via miR-616-3p/ADCY2 axis.

Journal: Molecular carcinogenesis

Published: January 31, 2023

ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD.

ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD.

Journal: Molecular oncology

Published: July 21, 2022

FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis.

FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis.

Journal: Annals of hematology

Published: July 14, 2022

The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia.

The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia.

Journal: Frontiers in oncology

Published: April 08, 2021

The crosstalk between m6A RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling.

The crosstalk between m6A RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling.

Journal: Theranostics

Published: October 25, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026